Physician profile
Michael G Enger
NPI 1609836188
$2,233.35
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,295 · 2020: $871 · 2021: $66.46.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $457.40 | 2019-2021 | |
| Amarin Pharma, INC. | $440.75 | 2019-2020 | |
| Amgen INC. | $349.10 | 2019-2020 | |
| Pfizer INC. | $203.65 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $136.58 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $102.27 | 2019-2020 | |
| Allergan, INC. | $82.95 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $82.43 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $61.31 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $58.55 | 2019-2021 | |
| Astellas Pharma US INC | $38.23 | 2020 | |
| Abbvie INC. | $34.02 | 2019-2021 | |
| Seqirus USA INC | $21.29 | 2019 | |
| Zyla Life Sciences, INC. | $19.42 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $18.56 | 2019 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $17.40 | 2019 | |
| Novo Nordisk INC | $15.12 | 2019 | |
| Sanofi Pasteur INC. | $14.46 | 2019 | |
| Amag Pharmaceuticals, INC. | $14.06 | 2019 | |
| Glaxosmithkline, LLC. | $13.98 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.46 | 2020 | |
| Therapeuticsmd, INC. | $13.33 | 2019 | |
| Shire North American Group INC | $12.90 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $12.13 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Enger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.